Simpson Thacher Represents Blackstone in Connection with the $14 Billion Acquisition of Biomet by Zimmer Holdings
06.25.15
This is only gets display when printing
The Firm is representing Blackstone in connection with Zimmer Holdings Inc.’s acquisition of Biomet Inc. from a consortium of private equity sponsors including Blackstone, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts & Co. LP and TPG Capital Management LP, in a cash and stock transaction valued at approximately $14 billion. The transaction was announced on April 24, 2014 and consummated on June 24, 2015.
In connection with the combination, Zimmer has changed its name to Zimmer Biomet Holdings, Inc. The combined company will be a global leader in musculoskeletal healthcare, which designs, manufactures and markets orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. The combined company will trade on the New York Stock Exchange and the SIX Swiss Exchange.
The Simpson Thacher team includes Jakob Rendtorff (M&A); and Jennifer Nadborny and James Rapp (Capital Markets and Securities).